Rankings
▼
Calendar
▼
COCH Q4 2020 Earnings Report — Envoy Medical, Inc. Revenue & Financial Results | Market Cap Arena
Envoy Medical, Inc.
COCH
Q4 2020 Earnings
Reported December 30, 2020
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
Q4 2020
Q3 2020
Q4 2019
QoQ Change
YoY Change
Revenue
$0
—
—
—
—
Op. Income
-$701
—
—
—
—
EPS (Diluted)
$-0.00
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$0
Selling & Marketing
$0
General & Administrative
$0
SG&A Expenses
$701
Other Expenses
$0
Operating Expenses
$701
Cost & Expenses
$701
OPERATING INCOME
-$701
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
$0
INCOME BEFORE TAX
-$701
Income Tax Expense
$0
Net Income from Continuing Ops
-$701
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$701
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$701
D&A
$0
EBIT
-$701
EBITDA
-$701
EPS
-$0
EPS Diluted
-$0
marketcaparena.com
← FY 2020
COCH Overview
Q1 2021 →